Quality of life assessment by allogeneic donors enrolled in a randomized study of marrow or peripheral blood stem cell (PBSC) transplantation.

被引:0
|
作者
Rowley, S [1 ]
Donaldson, G [1 ]
Lilleby, K [1 ]
Bensinger, W [1 ]
Appelbaum, F [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2699
引用
收藏
页码:607A / 607A
页数:1
相关论文
共 50 条
  • [41] Peripheral blood stem cells (PBSC) for allogeneic transplantation in multiple myeloma (MM).
    Majolino, I
    Tarella, C
    Scimè, R
    Santoro, A
    Corradini, P
    Cavallaro, AM
    Palumbo, A
    Indovina, A
    Caracciolo, D
    Boccadoro, M
    Marcenò, R
    Pileri, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S106 - S106
  • [42] Rhabdomyolysis in allogeneic peripheral blood stem cell donors
    Schanz, J
    Wolf, C
    Koehler, M
    Maas, JH
    Meyer, M
    Neumeyer, H
    Legler, TJ
    Wulf, G
    Glass, B
    Truemper, L
    Riggert, J
    VOX SANGUINIS, 2004, 86 (04) : 263 - 265
  • [43] Comparison of cell yields in a single-center, double-blind, randomized study of allogeneic marrow versus blood stem cell transplantation.
    Singhal, S
    Powles, R
    Kulkarni, S
    Treleaven, J
    Saso, R
    Long, S
    Rowland, A
    Millar, B
    Shepherd, V
    Cabral, S
    Mehta, J
    BLOOD, 1997, 90 (10) : 2631 - 2631
  • [44] Differential immuno-hematological reconstitution after allogeneic peripheral blood versus marrow hematopoietic stem cell transplantation.
    Lapierre, V
    Oubouzar, N
    Tramalloni, D
    Tayebi, H
    Robinet, E
    Kuentz, M
    Blaise, D
    Tiberghien, P
    BLOOD, 1998, 92 (10) : 140A - 140A
  • [45] Immune recovery after allogeneic peripheral blood stem cell (PBSC) transplantation: A comparative study of 78 patients.
    Charbonnier, A
    Sainty, D
    Arnoulet, C
    Faucher, C
    Viret, F
    Vey, N
    Stoppa, AM
    Chabannon, C
    Maraninchi, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 1998, 21 : S103 - S103
  • [46] Feasibility and efficacy of peripheral blood progenitor cell mobilisation with pegfilgrastim for allogeneic stem cell transplantation.
    Kroschinsky, F
    Hoelig, K
    Ordemann, R
    Haack, A
    Poppe-Thiede, K
    Blechschmidt, M
    Rall, G
    Bornhaeuser, M
    Schleyer, E
    Rutt, C
    Ehninger, G
    BLOOD, 2004, 104 (11) : 333B - 333B
  • [47] Allogeneic blood stem cell transplantation for hematologic malignancies: A safe effective alternative compared to allogeneic bone marrow transplantation.
    Mangan, KF
    Klumpp, TR
    BLOOD, 1998, 92 (10) : 353B - 353B
  • [48] Quality of life to Thai patients post bone marrow and peripheral blood stem cell transplantation
    Intragumtornchai, T
    Jootar, S
    Ungkanon, A
    Chancharunee, S
    Swasdikul, D
    Udomprasertkul, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 320 - 320
  • [49] Allogeneic blood stem cell transplantation: Considerations for donors
    Anderlini, P
    Korbling, M
    Dale, D
    Gratwohl, A
    Schmitz, N
    Stroncek, D
    Howe, C
    Leitman, S
    Horowitz, M
    Gluckman, E
    Rowley, S
    Przepiorka, D
    Champlin, R
    BLOOD, 1997, 90 (03) : 903 - 908
  • [50] Factors predictive of neutrophil engraftment following allogeneic peripheral blood stem cell transplantation.
    Klumpp, TR
    Herman, JH
    Sabol, PJ
    Mangan, KF
    BLOOD, 1999, 94 (10) : 358B - 358B